Elderly Patients With Diffuse Large B Cell Lymphoma Dlbcl clinical trials

Explore recruiting elderly patients with diffuse large b cell lymphoma dlbcl clinical trials.

Recruiting elderly patients with diffuse large b cell lymphoma dlbcl studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Elderly Patients With Diffuse Large B Cell Lymphoma Dlbcl trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Prephase treatment with prednisone +/- Vitamin D supplementation followed by immunochemotherapy in Elderly patients with Diffuse Large B-Cell Lymphoma (DLBCL). A randomized, open label, phase III study by Fondazione Italiana Linfomi.

Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

Elderly Patients With Diffuse Large B Cell Lymphoma Dlbcl trials by city

Elderly Patients With Diffuse Large B Cell Lymphoma Dlbcl clinical trials

Recruiting elderly patients with diffuse large b cell lymphoma dlbcl studies right now

CRP Regimen in Treating Elderly Patients With Previously Untreated Double-Positive DLBCL

Prephase Treatment With Prednisone +/- Vitamin D Supplementation Followed by Immunochemotherapy

Study of Acalabrutinib and Rituximab in Untreated Elderly and/or Frail Patients With DLBCL

Polatuzumab, Rituximab and Orelabrutinib Combination Regimen (PRO) in the Treatment of Elderly Frail Patients with Treatment-naive Non-GCB DLBCL

Chidamide Combination With R-mini CHOP Followed by Chidamide+CD20 Maintenance in Elderly Newly Diagnosed MYC/BCL2+ DLBCL

Pomalidomide, Rituximab and Orelabrutinib Combined With Polatuzumab Vedotin in the Treatment of Newly Diagnosed Elderly Patients With DLBCL

Clinical Study of HiR+X Therapy for Newly Diagnosed Elderly Patients With DLBCL Intolerant to Chemotherapy

A Prospective Clinical Study of the Combination Therapy of Obutinib or Decitabine with Rituximab, Cyclophosphamide, and Prednisone for the Primary Treatment of Elderly Patients with Newly Diagnosed Diffuse Large B-cell Lymphoma

A Study to Evaluate the Impact of Mosunetuzumab Consolidation for Older Patients With Diffuse Large B-cell Lymphoma (DLBCL) Who Have Detectable Amounts of ctDNA (Circulating Tumor DNA) at the End of Treatment With Pola-R-mini-CHP

Also recruiting in Europe

Prephase treatment with prednisone +/- Vitamin D supplementation followed by immunochemotherapy in Elderly patients with Diffuse Large B-Cell Lymphoma (DLBCL). A randomized, open label, phase III study by Fondazione Italiana Linfomi.

Elderly Patients With Diffuse Large B Cell Lymphoma Dlbcl trials by city

Other conditions